AstraZeneca
AstraZeneca and Isis Pharma in $65m drugs collaboration
August 3, 2015Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D
Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …
AstraZeneca receives US approval for Iressa
July 16, 2015Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer
AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …
The Partners hires creative director from InVentive
June 30, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Novo Nordisk, The International Aids Society, The partners, inventive, peter henshaw
Brand consultancy The Partners has appointed creative director Peter Henshaw to lead its creative offerings for the agency’s health team. …
Senior heads depart AstraZeneca and Takeda
June 25, 2015Medical Communications, Sales and Marketing AstraZeneca, Briggs Morrison, François-Xavier Roger, James Ward-Lilley, Takeda, brett wells
AstraZeneca vice president James Ward-Lilley and Takeda’s chief financial officer François-Xavier Roger are both exiting their respective companies and moving …
FDA accepts Teva asthma drug for review
June 15, 2015Sales and Marketing AstraZeneca, GlaxoSmithKline’s mepolizumab, Teva, benralizumab, bla, cinquil, reslizumab
Teva’s investigational biologic for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, Cinquil, has been accepted …
AstraZeneca head of R&D exits role
June 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison
Briggs Morrison who joined AstraZeneca in 2012 and played an instrumental part in defending its takeover by Pfizer, is abruptly …
AstraZeneca sets up production unit in Africa
June 9, 2015Manufacturing and Production, Sales and Marketing Africa, AstraZeneca, AstraZeneca al-Djazair, Novasep, algeria
AstraZeneca is embarking upon a joint venture that will involve the building of a new $125 million small-molecule plant in …
NICE Lynparza rejection labelled ‘hard to understand’
June 2, 2015Sales and Marketing AstraZeneca, NICE, lynparza, olaparib
AstraZeneca has appealed to the government to put ‘urgent transitional measures’ in place to make sure patients can access innovative …
AstraZeneca lung drug shines on
June 1, 2015Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar
AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …
Lilly and AstraZeneca collaborate on cancer trials
May 29, 2015Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I
AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …
Otsuka, ViiV and AstraZeneca named in ABPI code complaints
May 26, 2015Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Otsuka, PMCPA, ViiV
A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …
Amgen pulls out of psoriasis deal with AstraZeneca
May 26, 2015Sales and Marketing Amgen, AstraZeneca, psoriasis
Amgen has ended its agreement with AstraZeneca to develop a new biologic for psoriasis, because of the likelihood of ‘restrictive …
AstraZeneca building $285m biologics plant in Sweden
May 19, 2015Manufacturing and Production, Sales and Marketing AstraZeneca, Sweden, Södertälje, brett wells
AstraZeneca is spending around $285 million on a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The …
FDA issues more diabetes drug warnings
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Boehringer, J&J, JJ, lilly
The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …
AstraZeneca eyes success in immuno-oncology combinations
May 14, 2015Sales and Marketing ASCO, AZ, AstraZeneca, CTLA-4, MEDI4736
An investigational immuno-oncology drug combination from AstraZeneca has shown promise in its most recent trial, although concerns over its side …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
